Skip to main content
Clinical Trials/NCT04800575
NCT04800575UnknownNot Applicable

Comparison of the Efficacy of Sterile Gauze and Semi-permeable Film Dressing for Hemodialysis Non-tunneling Central Venous Catheter

Peking University People's Hospital1 site in 1 country154 target enrollmentStarted: May 17, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
154
Locations
1
Primary Endpoint
exit-site infection

Study Overview

Brief Summary

This prospective single center RCT aims to compare sterile gauze and tape versus Semi-permeable film dressing on the incidence of exit-site infection, CRBSIs (catheter-related bloodstream infections), skin irritation, total bacterial count, dressing intactness and cost-benefit, nursing workload in hemodialysis patients with a non-tunneled hemodialysis catheter.

Detailed Description

This prospective single center RCT aims to compare sterile gauze and tape versus Semi-permeable film dressing on the incidence of exit-site infection, CRBSIs (catheter-related bloodstream infections), skin irritation, total bacterial count, dressing intactness and cost-benefit, nursing workload in hemodialysis patients with a non-tunneled hemodialysis catheter.

154 eligible patients in our HD center will be enrolled consecutively and randomly allocated to one of the two groups according to computer-generated randomization sequences in a 1:1 ratio. Experiment group use semi-permeable film as dressing in exit-site of CVC, and a sterile gauze and tape in control group. Both groups share same disinfection and dressing change procedure. Dressings will be replaced per hemodialysis session, or as needed. Socio-demographic data and disease-related information will be collected, as well as catheterization site, physician, skin and exit status of the catheterization site at baseline. Data as listed in the beginning will be recorded in the next 2 weeks follow-up at every session, such as sign of exit-site infection, CRBSIs (catheter-related bloodstream infections), skin irritation and dryness, dressing intactness. Before the 2nd dressing change, skin around exit of CVC under dressing area will be swabbed by a cotton swab. Nursing time of dressing change will be recorded by a third nurses. Cost and benefit will be calculated and compared by the end.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • age more than 18 years; requiring hemodialysis treatment by non-tunneled CVC inserted through subclavian vein, femoral vein, internal jugular vein by nephrologists team, allowing sufficient blood flow; competent to provide informed consent.

Exclusion Criteria

  • current systemic antibiotic therapy as a result of bacteremia in the previous 21 days; pregnancy; with a known dermatitis at the exit site or known hypersensitivity to a component of either dressing; require antibiotic lock or antibiotic ointment in exit-site for infection prevention locally

Outcomes

Primary Outcomes

exit-site infection

Time Frame: before disinfectant and dressing change at every hemodialysis session within 2 weeks

redness, tenderness, swelling and/or with exudation within 2 cm around exit of CVC in the skin

Secondary Outcomes

  • catheter-related blood stream infection(CRBSI)(within 2-week follow-up or before withdrawn of hemodialysis therapy if the patient cannot reach 2 weeks)
  • skin erythema and dryness under the dressing area(before disinfectant and dressing change at every hemodialysis session within 2 weeks)
  • dressing intactness(before disinfectant and dressing change at every hemodialysis session within 2 weeks)
  • total bacterial count(Once only. At the time of the 2nd dressing change after CVC insertion of each patient(dressing change usually happened at each hemodialysis therapy session))
  • nursing time for dressing change(at any of the session, once only)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Liang Junqing

nurse

Peking University People's Hospital

Study Sites (1)

Loading locations...

Similar Trials